Literature DB >> 20682547

Antigen-specific activation thresholds of CD8+ T cells are independent of IFN-I-mediated partial lymphocyte activation.

Danushka K Wijesundara1, Sheetal Kumar, Mohammed Alsharifi, Arno Müllbacher, Matthias Regner.   

Abstract

Type-I IFN (IFN-I) are highly pleiotropic cytokines known to modulate immune responses and play an early central role in mediating antiviral defenses. We have shown that IFN-I mediate transient up-regulation of a distinct subset of lymphocyte surface activation markers on both B and T cells in vivo independent of cognate antigen: a state referred to as 'partial lymphocyte activation'. Here we investigated in vitro the possibility that partial lymphocyte activation may serve to lower the antigen-specific activation thresholds for T cells. We found that the kinetics of Ca(2+) flux in T cells responding to TCR cross-linking was not enhanced in partially activated T cells. Furthermore, following TCR stimulation with anti-cluster of differentiation (CD) 3 epsilon, a lower proportion of partially activated than naive T cells proliferated. In contrast, the proliferation of partially activated and naive ovalbumin peptide (OVAp, SIINFEKL) specific CD8(+) T cells (OT-I CD8(+) T cells) was similar when stimulated with OVAp. Surprisingly, using an enzyme-linked immunospot (ELISPOT) assay for IFN-gamma secretion, we found that a higher number of partially activated OT-I CD8(+) T cells expressed effector functions than did naive OT-I CD8(+) T cells. This is most readily explained by an increased survival of activated antigen-specific CD8(+) T cells from a pool of partially activated T cells than naive T cells. Overall, when examining the effects of early (Ca(2+) flux), intermediate (proliferation) or late events (IFN-gamma secretion) of T-cell activation, we found that partial activation promotes the survival but does not alter the antigen-specific activation thresholds of CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682547     DOI: 10.1093/intimm/dxq064

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  3 in total

1.  Decreased Expression of CD69 on T Cells in Tuberculosis Infection Resisters.

Authors:  Zhen-Yan Chen; Lei Wang; Ling Gu; Rong Qu; Douglas B Lowrie; Zhidong Hu; Wei Sha; Xiao-Yong Fan
Journal:  Front Microbiol       Date:  2020-08-07       Impact factor: 5.640

Review 2.  Unraveling the convoluted biological roles of type I interferons in infection and immunity: a way forward for therapeutics and vaccine design.

Authors:  Danushka Kumara Wijesundara; Yang Xi; Charani Ranasinghe
Journal:  Front Immunol       Date:  2014-08-29       Impact factor: 7.561

3.  Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus.

Authors:  Suyeon Hong; Shaobo Ruan; Zachary Greenberg; Mei He; Jodi L McGill
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.